Cignal™ C/EBP Reporter Assay Kit: CCS-001L
For Growth and Differentiation Pathway Analyses
Applications
Complete Array List
Pathway
Apoptosis
Biomarkers
Cell Cycle
Cytokine & Inflammation
ECM & Adhesion
Neuroscience
Signal Transduction
Stem Cell & Development
Toxicology & Drug ADME
Diseases
Cancer
Cardiovascular Diseases
CNS Disorders
Immune Disorders
Infectious Diseases
Metabolic Diseases
 
Description
The Cignal C/EBP Reporter Assay is designed to monitor the activity of C/EBP-regulated signal transduction pathways in cultured cells. The C/EBP, CCAAT/enhancer-binding protein, is a basic leucine zipper transcription factor and is involved in the regulation of mitotic growth arrest and differentiation. The C/EBP reporter is a mixture of an inducible C/EBP responsive luciferase construct and a constitutively expressing Renilla construct (40:1). The C/EBP-responsive luciferase construct encodes the firefly luciferase reporter gene under the control of a minimal (m)CMV promoter and tandem repeats of the C/EBP binding site. We have experimentally optimized the number of response elements as well as the intervening sequence between response elements to maximize the signal to noise ratio. The constitutively expressing Renilla construct encodes the Renilla luciferase reporter gene under the control of a CMV immediately early enhancer/promoter and acts as an internal control for normalizing transfection efficiencies and monitoring cell viability.
Using a simple dual-luciferase assay, you can easily monitor the activity of C/EBP-mediated signaling pathways and determine the effect of various treatments, such as gene knockdown, over-expression, and chemical compounds on those pathways. For more information about the Cignal Reporter Assays, please visit the Cignal Reporter Assay home page.
Useful Links
Pricing and Ordering Response Element Sequence Other Reporter Assays
User Manual Technology Overview Transfection Reagent
Register for Webinar  Technical Support  Technical Brochure
White Paper
Related Products
siRNA Arrays ChIP qPCR PCR Arrays
Materials Included / Packing List:
Please check the kit components immediately after you receive this package. SuperArray is only responsible for missing items reported within two (2) business days of receipt.

Kit Contents:
Component Specification Concentration (total volume)
C/EBP Reporter  A mixture of inducible C/EBP-responsive firefly luciferase construct and constitutively expressing Renilla luciferase construct (40:1).  (100 ng/µl; 500 µl)*
Negative control  A mixture of non-inducible firefly luciferase construct and constitutively expressing Renilla luciferase construct (40:1).  (100 ng/µl; 500 µl)
Positive control  A mixture of constitutively expressing GFP, constitutively expressing firefly luciferase, and constitutively expressing Renilla luciferase constructs (40:1:1).  (100 ng/µl; 250 µl)

* Supplied material provides sufficient reporter for 500 assays, using recommended 96-well plate transfection protocol. The number of assays per kit is a function of the assay plate format used (refer to Cignal Reporter Assay User Manual).

Storage Conditions: The Cignal reporter assay constructs are shipped ambient. Store all tubes at -20  ºC.

Brief Protocol: For Experienced Users
First time users, please refer to the complete protocol in the Cignal Reporter Assays User Manual.
  1. Dilute transfection-ready reporter, negative control, and positive control construct formulations.
  2. Dilute relevant test nucleic acids (siRNA, shRNA, miRNA, expression vector).
  3. Prepare appropriate combinations of reporter constructs, controls, and test nucleic acids.
  4. Transfect plasmid mixtures separately into replicate wells of your cell line of interest using an optimized transfection procedure for the cell line under study.
  5. If applicable, 16 to 24 hours post-transfection, treat the transfected cells with test proteins, peptides, or compounds of interest.
  6. Two (2) to three (3) days post-transfection, assay the activities of the signaling pathways under study, utilizing the dual luciferase assay.
How It Works

The Cignal Reporter Assays include pre-formulated, transfection-ready reporter, negative control, and positive control. The transcription factor reporter and negative control are transfected and subjected to experimental treatments, in parallel. Dual-luciferase results are calculated for each transfectant. The impact of the experimental treatments is determined by comparing the normalized luciferase activities of the reporter to the identically treated negative control, across the complete treatment regimen. The positive control serves as a control for transfection efficiency, by monitoring GFP expression, as well as a positive control for both the firefly and Renilla luciferase assays.

Performance Data

General performance

Average maximum response rate = 10.3
Average Z' factor at maximum response rate = 0.71
Average coefficient of variation (CV%) = 7.2%

Excellent signal to noise ratio

Cignal C/EBP reporter assay can measure upregulation of C/EBP transcription activity: 293-H cells were transfected with C/EBP reporter, negative control and positive control (for transfection protocol refer our user manual). After 16 hours of transfection, medium was changed to assay medium (Opti-MEM + 0.5% FBS + 0.1mM NEAA + 1mM Sodium pyruvate + 100 U/ml penicillin + 100 µg/ml streptomycin). After 24 hours of transfection, cells were treated with 10mM LiCl for 18 hours. Dual Luciferase assay was performed, and promoter activity values are expressed as arbitrary units using a Renilla reporter for internal normalization. Experiments were done in triplicates, and the standard deviation is indicated. Cignal C/EBP reporter assay has shown 10 fold increase in C/EBP transcription activity by 10 mM LiCl.

Copyright © 2008 SuperArray Bioscience Corporation